Protean eGov Technologies Ltd.
Protean eGov Technologies Ltd. Fundamental Analysis
Protean eGov Technologies Ltd. (PROTEAN.NS) shows weak financial fundamentals with a PE ratio of 22.89, profit margin of 10.02%, and ROE of 9.17%. The company generates $9.1B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 76.3/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze PROTEAN.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakPROTEAN.NS struggles to generate sufficient returns from assets.
Valuation Score
ExcellentPROTEAN.NS trades at attractive valuation levels.
Growth Score
ModeratePROTEAN.NS shows steady but slowing expansion.
Financial Health Score
ExcellentPROTEAN.NS maintains a strong and stable balance sheet.
Profitability Score
WeakPROTEAN.NS struggles to sustain strong margins.
Key Financial Metrics
Is PROTEAN.NS Expensive or Cheap?
P/E Ratio
PROTEAN.NS trades at 22.89 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, PROTEAN.NS's PEG of -36.25 indicates potential undervaluation.
Price to Book
The market values Protean eGov Technologies Ltd. at 2.04 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.21 times EBITDA. This signals the market has high growth expectations.
How Well Does PROTEAN.NS Make Money?
Net Profit Margin
For every $100 in sales, Protean eGov Technologies Ltd. keeps $10.02 as profit after all expenses.
Operating Margin
Core operations generate 6.65 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $9.17 in profit for every $100 of shareholder equity.
ROA
Protean eGov Technologies Ltd. generates $6.88 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Protean eGov Technologies Ltd. generates limited operating cash flow of $698.81M, signaling weaker underlying cash strength.
Free Cash Flow
Protean eGov Technologies Ltd. produces free cash flow of $623.97M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $15.36 in free cash annually.
FCF Yield
PROTEAN.NS converts 3.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
22.89
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-36.25
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.04
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.30
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.07
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.61
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.09
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How PROTEAN.NS Stacks Against Its Sector Peers
| Metric | PROTEAN.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 22.89 | 34.49 | Better (Cheaper) |
| ROE | 9.17% | 1124.00% | Weak |
| Net Margin | 10.02% | -133673.00% (disorted) | Strong |
| Debt/Equity | 0.07 | 7.86 | Strong (Low Leverage) |
| Current Ratio | 2.61 | 5.81 | Strong Liquidity |
| ROA | 6.88% | -308769.00% (disorted) | Weak |
PROTEAN.NS outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Protean eGov Technologies Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Innovation, High Beta
EPS CAGR
N/A
Industry Style: Growth, Innovation, High Beta
FCF CAGR
N/A
Industry Style: Growth, Innovation, High Beta